{"transactions":[{"id":758712,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":43166,"kind":"person","name":"Troupin Barbara","position":1,"cik":"0001627886","reported_name":"Troupin Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-05-29T22:10:18.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments commencing on the grant date of May 28, 2026, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date."}],"balance_after":70000,"derivative":{"exercise_price":2.84,"expiration_date":"2036-05-27","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001627886-26-000001","document":"form4-05292026_100513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627886/000162788626000001/form4-05292026_100513.xml","form_type":"4"}},{"id":1135261,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":43166,"kind":"person","name":"Troupin Barbara","position":1,"cik":"0001627886","reported_name":"Troupin Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-05-23T17:41:30.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments commencing on the grant date of May 21, 2025, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date."}],"balance_after":20000,"derivative":{"exercise_price":0.39,"expiration_date":"2035-05-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-25-014396","document":"form4-05232025_050527.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627886/000141588925014396/form4-05232025_050527.xml","form_type":"4"}},{"id":1259859,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":43166,"kind":"person","name":"Troupin Barbara","position":1,"cik":"0001627886","reported_name":"Troupin Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-02-20T00:30:02.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments following the grant date of March 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":3.59,"expiration_date":"2032-02-29","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-25-004754","document":"form4-02202025_120257.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1627886/000141588925004754/form4-02202025_120257.xml","form_type":"4"}},{"id":1259858,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":43166,"kind":"person","name":"Troupin Barbara","position":1,"cik":"0001627886","reported_name":"Troupin Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-02-20T00:30:02.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments following the grant date of March 1, 2022."}],"balance_after":40000,"derivative":{"exercise_price":0.785,"expiration_date":"2032-02-29","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-25-004754","document":"form4-02202025_120257.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627886/000141588925004754/form4-02202025_120257.xml","form_type":"4"}},{"id":1503646,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":43166,"kind":"person","name":"Troupin Barbara","position":1,"cik":"0001627886","reported_name":"Troupin Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-23T21:54:09.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments commencing on the grant date of May 22, 2024, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date."}],"balance_after":20000,"derivative":{"exercise_price":1.43,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-014358","document":"form4-05232024_090501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627886/000141588924014358/form4-05232024_090501.xml","form_type":"4"}},{"id":1881076,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":43166,"kind":"person","name":"Troupin Barbara","position":1,"cik":"0001627886","reported_name":"Troupin Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-23T22:12:04.000Z","date":"2023-05-22","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments commencing on the grant date of May 22, 2023, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date."}],"balance_after":20000,"derivative":{"exercise_price":0.65,"expiration_date":"2033-05-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-031720","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627886/000120919123031720/doc4.xml","form_type":"4"}},{"id":2344449,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":43166,"kind":"person","name":"Troupin Barbara","position":1,"cik":"0001627886","reported_name":"Troupin Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-08T22:46:39.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments following the grant date of March 1, 2022."}],"balance_after":40000,"derivative":{"exercise_price":3.59,"expiration_date":"2032-02-29","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-22-017194","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627886/000120919122017194/doc4.xml","form_type":"4"}},{"id":3998414,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":43166,"kind":"person","name":"Troupin Barbara","position":1,"cik":"0001627886","reported_name":"Troupin Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-13T21:04:31.000Z","date":"2018-03-09","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable at a rate of twenty-five percent of the total number of shares underlying the options on the one-year anniversary of March 9, 2018 (the \"Vesting Commencement Date\") and 1/48th of the total number of shares underlying the options each monthly anniversary of the vesting commencement date thereafter for so long as the recipient of the option provides continuous service to the issuer, such that the total number of shares underlying the options shall be fully vested on the four-year anniversary of the vesting commencement date."}],"balance_after":75000,"derivative":{"exercise_price":16.55,"expiration_date":"2028-03-08","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-18-019267","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627886/000120919118019267/doc4.xml","form_type":"4"}},{"id":4390827,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":43166,"kind":"person","name":"Troupin Barbara","position":1,"cik":"0001627886","reported_name":"Troupin Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-11T02:22:07.000Z","date":"2017-03-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable at a rate of twenty-five percent of the total number of shares underlying the options on the one-year anniversary of March 8, 2017 (the \"Vesting Commencement Date\") and 1/48th of the total number of shares underlying the options each monthly anniversary of the vesting commencement date thereafter for so long as the recipient of the option provides continuous service to the issuer, such that the total number of shares underlying the options shall be fully vested on the four-year anniversary of the vesting commencement date."}],"balance_after":40000,"derivative":{"exercise_price":17.35,"expiration_date":"2027-03-07","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-17-020014","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627886/000120919117020014/doc4.xml","form_type":"4"}},{"id":4560693,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":43166,"kind":"person","name":"Troupin Barbara","position":1,"cik":"0001627886","reported_name":"Troupin Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-10T22:38:03.000Z","date":"2016-11-08","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable at a rate of twenty-five percent of the total number of shares underlying the options on the one-year anniversary of October 3, 2016 (the \"Vesting Commencement Date\") and 1/48th of the total number of shares underlying the options each monthly anniversary of the Vesting Commencement Date thereafter for so long as the recipient of the option provides continuous service to the issuer, such that the total number of shares underlying the options shall be fully vested on the four-year anniversary of the Vesting Commencement Date."}],"balance_after":50000,"derivative":{"exercise_price":11.77,"expiration_date":"2026-11-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-16-149432","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1627886/000120919116149432/doc4.xml","form_type":"4"}}]}